As shown in Fig. 3j-l, the tumor volume and weight were lower in GATA2 knockdown groups in comparision to control groups, thereby suggesting that GATA2 promotes prostate cancer cell proliferation in vivo. This evidence concerns the gene GATA2 and prostate cancer.